United Kingdom· GB-APID-21302511000001108
Abelcet 100mg/20ml concentrate for dispersion for infusion vials
A medicinal product containing amphotericin b phospholipid complex, registered in United Kingdom by Teva UK Ltd.
Checked against NHS dm+d (United Kingdom) on
Informational only — not a medical device.
The record
At a glance
NHS dm+d (United Kingdom)- Active substance
- Amphotericin B phospholipid complex
- Manufacturer
- Teva UK Ltd
- Country
- United Kingdom (GB)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- NHS dm+d (United Kingdom)
- Last checked
- September 13, 2026
Packs & prices · 1
- gtin5060093000375
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Amphotericin b phospholipid complex in 16 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- FinlandAbelcetTeva Pharma B.V.
- SwitzerlandAmbisome
- United StatesAmBisomeAstellas Pharma US, Inc.
- PolandAbelcetTeva Pharmaceuticals Polska Sp. z o.o.
- CzechiaABELCET LIPID COMPLEXTeva Pharmaceuticals CR, s.r.o., Praha
- GermanyAmbisome LiposomalGilead Sciences Gmbh
- FranceAMBISOME liposomal 50 mg, poudre pour dispersion pour perfusionGILEAD SCIENCES
- NetherlandsAmBisome liposomale amfotericine B 50 mg, poeder voor dispersie voor infusieGilead Sciences Ireland UC
Authorised across Europe · EMA
The same active substance is authorised in 27 EEA countries. Names it is sold under:
- Austria · Ambisome Liposomal, Ampho-Moronal
- Belgium · Ambisome Liposomales, Amfotericine B Liposomaal Tillomed
- Bulgaria · Амфотерицин B Липозомал Тиломед
- Cyprus · Ambisome Liposomal, Amphotericin B Liposomal Tillomed
- Czechia · Abelcet Lipid Complex, Amfotericin B Liposomal Tillomed
- Germany · Ambisome Liposomal, Ampho-Moronal
- Denmark · Ambisome Liposomal
- Estonia · Amphotericin B Liposomal Tillomed
- Spain · Abelcet Complejo Lipídico, Ambisome Liposomal
- Finland · Ambisome Liposomal, Fungizone
- France · Ambisome Liposomal, Fungizone
- Greece · Ambisome Liposomal
- Hungary · Abelcet, Ambisome Liposzómás
- Ireland · Ambisome liposomal, Amphotericin B Liposomal Tillomed
- Iceland · Ambisome Liposomal
- Italy · Ambisome Liposomiale, Fungizone
- Luxembourg · Abelcet Lipid Complex, Ambisome Liposomales
- Latvia · Ambisome liposomāls, Amphotericin B Tillomed
- Malta · Ambisome Liposomal
- Netherlands · Ambisome liposomale, Amfotericine B Liposomaal Tillomed
- Norway · Ambisome Liposomal
- Poland · Abelcet, Ambisome Liposomal
- Portugal · Abelcet, Ambisome Lipossomal
- Romania · Ambisome liposomal, Amfotericină B Lipozomală Tillomed
- Sweden · Ambisome Liposomal, Amphotericin B Liposomal Tillomed
- Slovenia · Ambisome Liposomal, Amfotericin B Liposomal Tillomed
- Slovakia · Abelcet Lipid Complex
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/26dd442e-55b2-44d5-a286-9ea3d093ddab GET /v1/drugs/26dd442e-55b2-44d5-a286-9ea3d093ddab?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"apid": "21302511000001108",
"desc": "Abelcet 100mg/20ml concentrate for dispersion for infusion vials (Teva UK Ltd)",
"form": "Dispersion for infusion",
"vpid": "21302211000001105",
"source": "dmd",
"vtm_id": "2273391000001100",
"strength": "5 mg",
"substance": "Amphotericin B phospholipid complex",
"ingredient": "Amphotericin B phospholipid complex",
"supplier_code": "3849901000001105"
}See everything about amphotericin b phospholipid complex.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.